<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Animal

Research    Cancer    Funding    Animal

Four Collaborative Human/Canine Cancer Research Projects Receive Pilot Grant Funding

Four research projects conducted by University of Colorado Cancer Center members from the University of Colorado Anschutz Medical Campus and Colorado State University recently each received $50,000 pilot grant funding from the Joint Pilot Program of the CU Cancer Center and CSU Flint Animal Cancer Center.


Author Rachel Sauer | Publish Date May 26, 2022
Full Story

Research    Cancer    Animal

How human genetic data could help dogs fight cancer

Some of what we learn through the compassionate treatment of dogs with cancer goes on to help human patients. Now a study by researchers at University of Colorado Cancer Center and Colorado State University Flint Animal Cancer Center returns the favor: We know so many of the genetic changes that cause human cancer – the current study, recently published in the journal Molecular Cancer Therapeutics, sequences 33 canine cancer cell lines to identify “human” genetic changes could be driving these canine cancers, possibly helping veterinary oncologists use more human medicines to cure cancer in dogs.


Author Cancer Center | Publish Date June 25, 2019
Full Story

CU Cancer Center In the News

Cancer Health

2024 Cancer Health 25: People Who Power Clinical Trials

news outletCancer Health
Publish DateJune 11, 2024

This year's Cancer Health 25 highlights the transformative power and promise of clinical trials. University of Colorado Cancer Center member Jessica McDermott, MD, MSCS, is leading clinical trials at both the CU Cancer Center and the Rocky Mountain Regional Veterans Affairs Medical Center. Additionally, she serves as the CU Cancer Center's deputy associate director for diversity and inclusion in clinical research.

Full Story
Cancer Network

Learning to “Aim High” Within Male-Dominated Fields in Public Health

news outletCancer Network
Publish DateJune 10, 2024

Cathy Bradley, PhD, deputy director of the Colorado University Cancer Center and dean of the Colorado School of Public Health, is a trailblazer in health economics. At a Breaking Barriers: Women in Oncology discussion, she shared insights on overcoming challenges as a woman in a male-dominated field and discussed her research on the impact of employment on cancer patients' health insurance decisions.

Full Story
Cancer Therapy Advisor

Telisotuzumab Vedotin Yields Durable Responses in c-Met-Expressing NSCLC

news outletCancer Therapy Advisor
Publish DateJune 07, 2024

Telisotuzumab vedotin shows promising activity in previously treated, c-Met-overexpressing, EGFR-wild-type nonsquamous non-small cell lung cancer (NSCLC), as presented by CU Cancer Center member David Ross Camidge, MD, PhD, at the ASCO Annual Meeting 2024. This phase 2 LUMINOSITY trial (NCT03539536) involved 161 patients with advanced or metastatic NSCLC and the overall response rate was 28.6%, with median progression-free survival of 5.7 months and median overall survival of 14.5 months.

Full Story
Association of Cancer Care Centers

The Centralized Tracking and Management of Incidental Lung Nodule Findings

news outletAssociation of Cancer Care Centers
Publish DateJune 07, 2024

The University of Colorado Cancer Center has been honored with the 2024 ACCC Innovator Award for creating a community-wide safety net for the centralized tracking and management of incidental lung nodule findings. This innovative approach led to a 2,514% increase in actively managed patients. To handle this surge, the center employs enterprise intelligence software to automatically analyze imaging results and identify high-risk patients, reducing patient wait times from 34 days to 5 days. ACCCBuzz interviewed Nina Thomas, MD, director of the Thoracic Malignancy Pillar, to discuss this achievement.

Full Story